The race to develop effective cancer vaccines has entered a new phase, with late-stage trials from companies like Moderna ...

PFE's non-oncology portfolio draws focus in Q2, with strength in Vyndaqel and Nurtec offsetting some vaccine softness.

As the prosecution has not appealed the ruling, the acquittal of Ilze Viņķele for official misconduct has come into force.

Discover how cutting-edge AI products are transforming industries, boosting innovation, and shaping Africa’s tech future and ...

The exanthema market is projected to grow from USD 1.39 billion in 2024 to USD 2.51 billion by 2034 at a CAGR of 6.10%. This growth is driven by risi ...

The melanoma market is predicted to surge during the forecast period (2025–2034) owing to factors, as the increasing incidence of melanoma, the launc ...

Sotyktu (deucravacitinib) has been assigned a Prescription Drug User Fee Act (PDUFA) goal date of March 6, 2026.

Germany’s BionNTech SE is laying off workers in Cambridge as part of a broader move to make "targeted adjustments to our U.S.

Steve Bates OBE appointed to help champion research and innovation and the use of technology to transform health and grow the ...

A global biotech is axing more of its Greater Washington workforce, eliminating nearly 100 positions across multiple waves of ...

While no vision loss was noted, researchers observed slight corneal thickening and decreased endothelial cell count, ...